[Acute monoblastic leukemia (M5a) with dysmegakaryocytopoiesis associated with t(16;21) (p11;q22)]

Rinsho Ketsueki. 1994 Feb;35(2):160-4.
[Article in Japanese]

Abstract

We report a 24-year-old woman who had acute monoblastic leukemia associated with t(16;21) (p11;q22). She was referred to our hospital in April 1992 because of high fever and hemorrhagic diathesis. Physical examination on admission showed no hepatosplenomegaly. The hemoglobin was 5.1g/dl, platelet count 1.7 x 10(4)/microliters, the white blood cell count 18,700/microliters. Bone marrow aspirate showed that 86% of nucleated cells were monoblasts which were positive for peroxidase and alpha-naphtyl butyrate esterase. She was diagnosed as having M5a. Dysmegakaryopoiesis, such as micromegakaryocytes and megakaryocytes with multiple small separated nuclei, was seen in the bone marrow. Chromosomal analysis revealed t(16;21). Complete remission was achieved after two courses of BHAC-DMP therapy, but dysmegakaryopoietic features remained. She relapsed in September 1992. Review of the literature and this patient indicate that acute nonlymphocytic leukemia with t(16;21) is associated with multilineage leukemic differentiation.

Publication types

  • Case Reports
  • Review

MeSH terms

  • Adult
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Chromosomes, Human, Pair 16*
  • Chromosomes, Human, Pair 21*
  • Cytarabine / administration & dosage
  • Cytarabine / analogs & derivatives
  • Daunorubicin / administration & dosage
  • Female
  • Hematopoiesis
  • Humans
  • Leukemia, Monocytic, Acute / drug therapy
  • Leukemia, Monocytic, Acute / genetics*
  • Leukemia, Monocytic, Acute / pathology
  • Megakaryocytes / pathology*
  • Mercaptopurine / administration & dosage
  • Prednisolone / administration & dosage
  • Translocation, Genetic*

Substances

  • Cytarabine
  • Prednisolone
  • Mercaptopurine
  • Daunorubicin

Supplementary concepts

  • BH-AC-DMP protocol